The investigators said they were surprised to see that patients with well-controlled blood sugar had lower mortality rates compared with those with poorly controlled levels. Furthermore, those with well-managed T2D also received fewer medical interventions, including supplemental oxygen or ventilation, and had fewer overall complications.
“We were surprised to see such favorable outcomes in [the] well-controlled blood glucose group among patients with COVID-19 and pre-existing type 2 diabetes,” said senior author Hongliang Li, MD, in a statement. “Considering that people with diabetes had much higher risk for death and various complications, and there are no specific drugs for COVID-19, our findings indicate that controlling blood glucose well may act as an effective auxiliary approach to improve the prognosis of patinets with COVID-19 and pre-existing diabetes.”
Pharmacy Times
Leave a Reply